In the BioHarmony Drug Report Database

"Preview" Icon

Digoxin

Digoxin, Lanoxicaps, Lanoxin, Lanoxin Pediatric (digoxin) is a small molecule pharmaceutical. Digoxin was first approved as Digoxin on 1982-01-01. It is used to treat anxiety disorders, atrial fibrillation, atrial flutter, cardiogenic shock, and heart failure amongst others in the USA. The pharmaceutical is active against sodium/potassium-transporting ATPase subunit alpha-1.

 

Trade Name

 

Digoxin, Lanoxicaps, Lanoxin, Lanoxin Pediatric
 

Common Name

 

digoxin
 

ChEMBL ID

 

CHEMBL1751
 

Indication

 

anxiety disorders, atrial fibrillation, atrial flutter, cardiogenic shock, heart failure, low cardiac output, supraventricular tachycardia
 

Drug Class

 

Fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics)

Image (chem structure or protein)

Digoxin structure rendering